Standout Papers

A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depressio... 2006 2026 2012 2019 2.6k
  1. A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression (2006)
    Carlos A. Zarate, Jaskaran Singh et al. Archives of General Psychiatry
  2. Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression (2017)
    Ella Daly, Jaskaran Singh et al. JAMA Psychiatry
  3. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study (2019)
    Vanina Popova, Ella Daly et al. American Journal of Psychiatry
  4. Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study (2018)
    Carla M. Canuso, Jaskaran Singh et al. American Journal of Psychiatry
  5. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1) (2019)
    Maggie Fedgchin, Madhukar H. Trivedi et al. The International Journal of Neuropsychopharmacology

Immediate Impact

1 by Nobel laureates 43 from Science/Nature 129 standout
Sub-graph 1 of 14

Citing Papers

Psychedelics reopen the social reward learning critical period
2023 StandoutNature
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
2023 Standout
92 intermediate papers

Works of Jaskaran Singh being referenced

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
2019 Standout
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
2019
and 21 more

Author Peers

Author Last Decade Papers Cites
Jaskaran Singh 5029 2013 3994 2480 92 7.8k
Nancy E. Brutsché 5838 1348 4806 2709 34 7.6k
Amit Anand 2945 1805 2446 2460 115 7.8k
Rezvan Ameli 2720 1510 2254 1941 54 6.6k
Dan A. Oren 2399 1071 2037 1819 72 5.3k
Sanjay J. Mathew 5983 1935 5108 2928 179 10.9k
Michael E. Thase 5706 3347 2385 1153 100 9.7k
Rodrigo Machado‐Vieira 3245 4017 4565 2605 188 10.8k
Nancy Diazgranados 2575 1122 2198 1309 77 4.3k
Daniel Souery 2390 2171 2033 880 204 6.5k
Jeffrey H. Meyer 2038 1468 2352 3399 149 9.7k

All Works

Loading papers...

Rankless by CCL
2026